Mo1496: USE OF BIOLOGICS DOES NOT INCREASE THE RISK OF MALIGNANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND PRIMARY SCLEROSING CHOLANGITIS | Publicación